TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 21355649

Group type: EXPERIMENTAL
Intervention: Video-feedback intervention to promote positive parenting-child care (VIPP-CC)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 48
Study: 16209160

Group type: EXPERIMENTAL
Intervention: Niacinamide-containing facial moisturizer applied to the face and one forearm twice daily for 4 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Untreated forearm (Control)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Self-assessment of facial skin condition by subjects
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Dermatologist evaluation of rosacea condition
Number of subjects: 50
Study: 12590721

Group type: EXPERIMENTAL
Intervention: Bare bones protocol
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control method
Number of subjects: 50
Study: 9881074

Group type: EXPERIMENTAL
Intervention: Postoperative radiochemotherapy (RCT) + chemotherapy (CT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Preoperative neoadjuvant radiotherapy (RT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Postoperative adjuvant RT
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Preoperative RCT + CT
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intraoperative RT
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pre- or postoperative RCT + CT
Number of subjects: 0
Study: 7708069

Group type: EXPERIMENTAL
Intervention: Lipiodol chemoembolization (70 mg of cisplatin, 10 ml of lipiodol, and gelatin‐sponge particles delivered through the hepatic artery)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Conservative management (treatment of complications and pain)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Lipiodol chemoembolization
Number of subjects: 96
Study: 2706885

Group type: EXPERIMENTAL
Intervention: Heparin lock catheter (n=17)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Continuous intravenous line (n=22)
Number of subjects: 39
Study: 139565

Group type: EXPERIMENTAL
Intervention: Spectinomycin (2 or 4 g once)
Number of subjects: 4043

Group type: EXPERIMENTAL
Intervention: Tetracycline (9 g orally for four days)
Number of subjects: 4043
Study: 11436953

Group type: EXPERIMENTAL
Intervention: Sertraline treatment for 14 weeks
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Sertraline group
Number of subjects: 11
Study: 30710258

Group type: EXPERIMENTAL
Intervention: DEX‐Sevo (dexmedetomidine-sevoflurane)
Number of subjects: 143

Group type: COMPARATOR
Intervention: Sevo (sevoflurane)
Number of subjects: 143
Study: 29702133

Group type: EXPERIMENTAL
Intervention: Bio-K+ probiotic formulation (Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R, Lactobacillus rhamnosus CLR2)
Number of subjects: 0
Study: 27037722

Group type: EXPERIMENTAL
Intervention: Telehealth programme (MASTERY©) supported by a handheld respiratory device and an Android smartphone application (Breathe-easy©) and written asthma action plan
Number of subjects: 72

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 72
Study: 24356624

Group type: EXPERIMENTAL
Intervention: Axitinib (5 mg twice daily) with paclitaxel (200 mg/m2 Q3W)/carboplatin (AUC 6 mg min/ml Q3W)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Bevacizumab (15 mg/kg every 3 weeks) with paclitaxel (200 mg/m2 Q3W)/carboplatin (AUC 6 mg min/ml Q3W)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Axitinib/paclitaxel/carboplatin
Number of subjects: 118

Group type: COMPARATOR
Intervention: Bevacizumab/paclitaxel/carboplatin
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 118
Study: 22223702

Group type: EXPERIMENTAL
Intervention: Myo-inositol (MYO) 1200 mg/day for 12 weeks
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 21073267

Group type: EXPERIMENTAL
Intervention: Nurse-led patient education programme and care plan (including lifestyle changes, home-based exercise training, weekly nurse consultations)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Nurse-led patient education programme and care plan
Number of subjects: 85

Group type: COMPARATOR
Intervention: Control group managed according to Russian national guidelines
Number of subjects: 85
Study: 17714542

Group type: EXPERIMENTAL
Intervention: Stimulation of sucking and swallowing (one daily session of stimulation according to Vojta)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Standard nursing care (no intervention)
Number of subjects: 36
Study: 16918151

Group type: EXPERIMENTAL
Intervention: Simple health education program
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 200
Study: 12107604

Group type: COMPARATOR
Intervention: Leukotriene receptor antagonists
Number of subjects: 52
Study: 9657565

Group type: EXPERIMENTAL
Intervention: Budesonide (600 microg b.i.d.)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 8593200

Group type: EXPERIMENTAL
Intervention: Stabilized stannous fluoride (SnF2) dentifrice (SSF)
Number of subjects: 188
Study: 2782247

Group type: EXPERIMENTAL
Intervention: Controlled-release isosorbide-5-mononitrate (ISMN) 60 mg daily
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Immediate-release isosorbide dinitrate (ISDN) 30 mg, 4 times daily
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 935199

Group type: EXPERIMENTAL
Intervention: Propranolol (40 mg, 6 doses, given at 6 hour intervals)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 18
Study: 31951323

Group type: EXPERIMENTAL
Intervention: Adaptive Servo Ventilation (ASV)
Number of subjects: 1325

Group type: EXPERIMENTAL
Intervention: Circulating biomarkers
Number of subjects: 1325

Group type: COMPARATOR
Intervention: Control
Number of subjects: 1325
Study: 30889857

Group type: EXPERIMENTAL
Intervention: Randomized Response Technique (RRT)
Number of subjects: 0
Study: 28213743

Group type: EXPERIMENTAL
Intervention: CER-001 (0.25-45.0 mg/kg)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: CER-001 (2 mg/kg and above)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 26531066

Group type: EXPERIMENTAL
Intervention: Accelerated, multiple, double-dose HB vaccine (40 μg) administered at 0, 1, and 3 weeks before chemotherapy and additional three double doses post chemotherapy.
Number of subjects: 926

Group type: COMPARATOR
Intervention: Conventional HB vaccine (20 μg) administered at 0, 1, and 6 months.
Number of subjects: 926
Study: 23208320

Group type: COMPARATOR
Intervention: Mirabegron 100 mg single oral dose
Number of subjects: 8
Study: 21947655

Group type: EXPERIMENTAL
Intervention: Behavioural activation
Number of subjects: 47

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 47
Study: 18465340

Group type: EXPERIMENTAL
Intervention: Tamoxifen for 1 year (TAM1)
Number of subjects: 1615

Group type: EXPERIMENTAL
Intervention: Tamoxifen for 2 years (TAM2)
Number of subjects: 1615

Group type: EXPERIMENTAL
Intervention: Tamoxifen for 6 months followed by megestrol acetate for 6 months (TAM/MA)
Number of subjects: 1615
Study: 16532442

Group type: EXPERIMENTAL
Intervention: Radiofrequency treatment (Thermage ThermaCool TC) delivered at 63.5 setting with medium-fast 1.5 cm2 tip over injected sites.
Number of subjects: 5

Group type: COMPARATOR
Intervention: Control group with augmentation materials alone (no RF treatment).
Number of subjects: 5
Study: 12435653

Group type: EXPERIMENTAL
Intervention: Physical therapy (N = 33)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Placebo treatment (N = 34)
Number of subjects: 71
Study: 10332683

Group type: EXPERIMENTAL
Intervention: Repaglinide
Number of subjects: 43

Group type: COMPARATOR
Intervention: Glyburide
Number of subjects: 43
Study: 7488454

Group type: EXPERIMENTAL
Intervention: DDD pacing
Number of subjects: 20

Group type: COMPARATOR
Intervention: VVIR pacing
Number of subjects: 20

Group type: COMPARATOR
Intervention: VVI pacing
Number of subjects: 20
Study: 2036245

Group type: EXPERIMENTAL
Intervention: levamisole (2.5 mg/kg on two consecutive days every week except on chemotherapy days)
Number of subjects: 101

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: levamisole
Number of subjects: 101
Study: 7023596

Group type: EXPERIMENTAL
Intervention: General anaesthesia
Number of subjects: 100

Group type: COMPARATOR
Intervention: Epidural anaesthesia
Number of subjects: 100

Group type: COMPARATOR
Intervention: Local anaesthesia
Number of subjects: 100
Study: 31560220

Group type: EXPERIMENTAL
Intervention: Anthropometry-based nomogram for predicting metabolic syndrome
Number of subjects: 60799
Study: 29564491

Group type: EXPERIMENTAL
Intervention: Tendon-to-bone repair (87 hips)
Number of subjects: 159

Group type: COMPARATOR
Intervention: Tendon-to-tendon repair (80 hips)
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 159
Study: 27922626

Group type: EXPERIMENTAL
Intervention: Strength training
Number of subjects: 30

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 30
Study: 26966776

Group type: EXPERIMENTAL
Intervention: Caries management strategy 1
Number of subjects: 1124

Group type: EXPERIMENTAL
Intervention: Caries management strategy 2
Number of subjects: 1124

Group type: EXPERIMENTAL
Intervention: Caries management strategy 3
Number of subjects: 1124
Study: 24012579

Group type: EXPERIMENTAL
Intervention: Group-based cognitive rehabilitation intervention
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 28
Study: 21455768

Group type: EXPERIMENTAL
Intervention: Laser-treated retinopathy of prematurity (n = 7)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Spontaneously regressed ROP (n = 8)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: No ROP (n = 10)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (age-matched full-term children, n = 8)
Number of subjects: 25
Study: 18288492

Group type: EXPERIMENTAL
Intervention: K198N coding polymorphism in EDN1
Number of subjects: 0
Study: 16221935

Group type: EXPERIMENTAL
Intervention: Telemedicine case management
Number of subjects: 1665

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1665
Study: 12816220

Group type: EXPERIMENTAL
Intervention: APC tonsillectomy (treatment B)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional tonsillectomy (treatment A)
Number of subjects: 40
Study: 11191692

Group type: EXPERIMENTAL
Intervention: Modafinil
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Dextroamphetamine
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 9145871

Group type: EXPERIMENTAL
Intervention: Artemisinin capsules (500 mg) administered with food
Number of subjects: 6

Group type: COMPARATOR
Intervention: Artemisinin capsules (500 mg) administered without food
Number of subjects: 6
Study: 7698137

Group type: EXPERIMENTAL
Intervention: k-strophanthidin (0.0035 mg.kg-1 for 10 min)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: dobutamine (10 micrograms.kg-1.min-1 for 10 min)
Number of subjects: 22
Study: 2455126

Group type: EXPERIMENTAL
Intervention: Diltiazem (20 mg/l in Eurocollin's solution, bolus injection of 0.28 mg/kg, continuous infusion of 0.002 mg/min/kg for 2 days, then 60 mg orally twice daily)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Diltiazem (same regimen as Study I without donor pretreatment)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control group (no diltiazem)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Diltiazem treatment group
Number of subjects: 63
Study: 29699757

Group type: EXPERIMENTAL
Intervention: Active treatment period
Number of subjects: 139

Group type: COMPARATOR
Intervention: Placebo run-in period (PRI)
Number of subjects: 139
Study: 27790252

Group type: COMPARATOR
Intervention: 6% sodium hypochlorite (NaOCl) irrigation (single session treatment)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Calcium hydroxide (CH) mixed with 0.2% chlorhexidine (CHX) as intracanal medicament for two weeks
Number of subjects: 0
Study: 25436073

Group type: EXPERIMENTAL
Intervention: Alternate Sequential Compression Device (ASCD)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Simultaneous Sequential Compression Device (SSCD)
Number of subjects: 34
Study: 23415342

Group type: EXPERIMENTAL
Intervention: Online Evidence-based Medicine course (immediate intervention group, n=58)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Waiting control group (n=62)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Both groups throughout the course
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Course evaluation
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Course grading
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Interest in further teaching activities
Number of subjects: 120
Study: 20100336

Group type: EXPERIMENTAL
Intervention: Direct endomyocardial autologous bone marrow cell injection
Number of subjects: 12
Study: 17141245

Group type: EXPERIMENTAL
Intervention: Pravastatin 40 mg
Number of subjects: 276

Group type: EXPERIMENTAL
Intervention: Fosinopril 20 mg
Number of subjects: 276

Group type: COMPARATOR
Intervention: Matching placebo for pravastatin
Number of subjects: 276

Group type: COMPARATOR
Intervention: Matching placebo for fosinopril
Number of subjects: 276
Study: 16368814

Group type: EXPERIMENTAL
Intervention: Nefopam 20 mg intraoperatively
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Large-dose remifentanil (Group L: 8 ng/mL)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Small-dose remifentanil (Group S: 3 ng/mL)
Number of subjects: 60
Study: 12076293

Group type: EXPERIMENTAL
Intervention: Transfusion trigger
Number of subjects: 428

Group type: EXPERIMENTAL
Intervention: Number of RBC units transfused
Number of subjects: 428

Group type: EXPERIMENTAL
Intervention: Transfusion decision
Number of subjects: 428
Study: 9805694

Group type: EXPERIMENTAL
Intervention: General anesthesia only
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: General anesthesia supplemented by fentanyl (4 micrograms/kg)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: General anesthesia combined with epidural anesthesia (1% mepivacaine)
Number of subjects: 52
Study: 7715291

Group type: EXPERIMENTAL
Intervention: Fluorouracil and folinic acid (370-400 mg/m2 plus 200 mg/m2 daily for 5 days, every 28 days for 6 cycles)
Number of subjects: 1493

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 1493
Study: 2707458

Group type: EXPERIMENTAL
Intervention: Clomiphene citrate (CC) (100 mg) by mouth on cycle days 5 to 9
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Human chorionic gonadotropin (hCG) (5,000 IU) intramuscularly on cycle days 19, 22, 25, and 28
Number of subjects: 148

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Treatment-independent pregnancies (before treatment or more than 1 month after therapy)
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: In vitro fertilization (IVF)
Number of subjects: 148
Study: 2377

Group type: EXPERIMENTAL
Intervention: Lorazepam
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pantopon
Number of subjects: 0
Study: 7343127

Group type: EXPERIMENTAL
Intervention: Mass drug administration (chemoprophylaxis) given every 15 days
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 31774411

Group type: EXPERIMENTAL
Intervention: Run4Love mHealth intervention
Number of subjects: 300
Study: 28104830

Group type: EXPERIMENTAL
Intervention: High flow oxygen therapy (HFOT)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Non-invasive ventilation (NIV)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Baseline
Number of subjects: 14
Study: 27931242

Group type: EXPERIMENTAL
Intervention: GOAL intervention (goal-setting intervention)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 48
Study: 24434951

Group type: EXPERIMENTAL
Intervention: Weight stigmatizing video
Number of subjects: 123

Group type: COMPARATOR
Intervention: Neutral video
Number of subjects: 123
Study: 22996350

Group type: EXPERIMENTAL
Intervention: Passive heating (HT)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Cooling (CL)
Number of subjects: 10
Study: 18987560

Group type: EXPERIMENTAL
Intervention: Congenital spastic hemiplegia group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Typically developing children
Number of subjects: 0
Study: 17300543

Group type: EXPERIMENTAL
Intervention: Symptom management program (10 sessions)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 18
Study: 14693596

Group type: EXPERIMENTAL
Intervention: Cisatracurium 0.15 mg/kg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rocuronium 0.60 mg/kg
Number of subjects: 0
Study: 11981422

Group type: EXPERIMENTAL
Intervention: XM-positive BSCT
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (matched for disease, disease stage, patient age, period of transplant, conditioning regimen, protocol for prevention of graft-versus-host disease, type of donor)
Number of subjects: 60
Study: 9618627

Group type: EXPERIMENTAL
Intervention: Aerobic exercise classes
Number of subjects: 99

Group type: COMPARATOR
Intervention: Standard physical education classes
Number of subjects: 99
Study: 7714113

Group type: EXPERIMENTAL
Intervention: Insulin infusion during euglycemic conditions
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Insulin infusion during hyperglycemic conditions
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Insulin infusion
Number of subjects: 2

Group type: COMPARATOR
Intervention: Insulin infusion during hyperglycemic vs euglycemic conditions
Number of subjects: 2
Study: 2695820

Group type: EXPERIMENTAL
Intervention: Benzoyloxymethyl-thiamin
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 926982

Group type: EXPERIMENTAL
Intervention: Silymarine
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 31478708

Group type: EXPERIMENTAL
Intervention: Activity trackers with online coach
Number of subjects: 116

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 116
Study: 31302707

Group type: EXPERIMENTAL
Intervention: Annual substantial decrease in eGFR (lowest 25%, < -1.63 ml min-1 [1.73 m]-2 year-1)
Number of subjects: 8879

Group type: COMPARATOR
Intervention: Stable change in eGFR (middle 50%, -1.63 to 0.33)
Number of subjects: 8879

Group type: EXPERIMENTAL
Intervention: Annual substantial increase in eGFR (highest 25%, > 0.33)
Number of subjects: 8879
Study: 28256257

Group type: EXPERIMENTAL
Intervention: Single-incision laparoscopic cholecystectomy
Number of subjects: 187

Group type: COMPARATOR
Intervention: 3-port laparoscopic cholecystectomy
Number of subjects: 187
Study: 24388222

Group type: EXPERIMENTAL
Intervention: Escitalopram treatment
Number of subjects: 100
Study: 25618971

Group type: EXPERIMENTAL
Intervention: Pulsatile perfusion (n = 17)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Non-pulsatile perfusion (n = 17)
Number of subjects: 34
Study: 22818896

Group type: EXPERIMENTAL
Intervention: Intravitreal injections of bevacizumab every 6 weeks for the first 3 injections followed by injections every 6 weeks (regimen A, n = 91)
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Intravitreal injections of bevacizumab every 12 weeks (regimen B, n = 94)
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Regimen A
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Regimen B
Number of subjects: 185
Study: 19206044

Group type: EXPERIMENTAL
Intervention: Intravitreal triamcinolone acetonide injection
Number of subjects: 114

Group type: COMPARATOR
Intervention: Orbital floor triamcinolone acetonide injection
Number of subjects: 114
Study: 17189654

Group type: EXPERIMENTAL
Intervention: Home telemonitoring of vital signs and respiration (weekly monitoring of 12 parameters, monthly 24-hour recording)
Number of subjects: 461

Group type: EXPERIMENTAL
Intervention: Home telemonitoring of vital signs and respiration
Number of subjects: 461

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 461
Study: 15712724

Group type: EXPERIMENTAL
Intervention: Fetal independent components retrieved with an ICA algorithm (FastICA) and interpolated using fICI method
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard technique for fetal mapping
Number of subjects: 0
Study: 12040968

Group type: EXPERIMENTAL
Intervention: 20 mg ambroxol hydrochloride
Number of subjects: 714

Group type: EXPERIMENTAL
Intervention: 30 mg ambroxol hydrochloride
Number of subjects: 714

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 714
Study: 9791656

Group type: EXPERIMENTAL
Intervention: Ambulatory surgery with local anal block
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional inpatient surgery with regional anaesthesia
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both groups (Ambulatory and Inpatient)
Number of subjects: 80
Study: 9098471

Group type: EXPERIMENTAL
Intervention: Echoguide embryo transfer (ultrasound control)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Clinical feel method (without ultrasound control)
Number of subjects: 132
Study: 2533410

Group type: EXPERIMENTAL
Intervention: Sodium metabisulphite aerosol (0.3 to 160 mg/ml)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Sodium metabisulphite aerosol (PD20 dose)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Sodium metabisulphite (second inhalation of same PD20 dose)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Ipratropium bromide 200 micrograms
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: PD20 metabisulphite measurements
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: PD20 metabisulphite
Number of subjects: 18
Study: 727428

Group type: EXPERIMENTAL
Intervention: 4 mg of domperidone
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Domperidone
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study: 30928396

Group type: EXPERIMENTAL
Intervention: Liposomal bupivacaine (LB)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Interscalene block alone (Control)
Number of subjects: 50
Study: 28257731

Group type: EXPERIMENTAL
Intervention: Vacuum-formed retainer
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Hawley retainer fabricated by chemical cure
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Hawley retainer fabricated by heat cure
Number of subjects: 45